Pearl River Capital’s Pfizer PFE Stock Holding History

Pearl River Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-235,388	Closed	-$6.59M	–	281
2024 Q2	$6.59M	Buy	+235,388	New	+$6.48M	1.05%	14
2023 Q3	–	Sell	-142,696	Closed	-$5.23M	–	580
2023 Q2	$5.23M	Buy	+142,696	New	+$5.55M	0.84%	15
2022 Q4	–	Sell	-159,952	Closed	-$7M	–	567
2022 Q3	$7M	Buy	159,952 +75,635	+90%	+$3.68M	1.3%	1
2022 Q2	$4.42M	Buy	84,317 +63,040	+296%	+$3.21M	1.04%	5
2022 Q1	$1.1M	Sell	21,277 -14,801	-41%	-$768K	0.3%	100
2021 Q4	$2.13M	Sell	36,078 -13,614	-27%	-$675K	0.58%	41
2021 Q3	$2.14M	Sell	49,692 -15,054	-23%	-$667K	0.58%	37
2021 Q2	$2.54M	Buy	+64,746	New	+$2.52M	0.7%	25
2021 Q1	–	Sell	-97,765	Closed	-$3.6M	–	494
2020 Q4	$3.6M	Buy	+97,765	New	+$3.59M	1.29%	1
2020 Q3	–	Sell	-46,950	Closed	-$1.46M	–	440
2020 Q2	$1.46M	Buy	46,950 +42,149	+878%	+$1.43M	0.72%	36
2020 Q1	$149K	Sell	4,801 -48,281	-91%	-$1.65M	0.29%	123
2019 Q4	$1.97M	Buy	+53,082	New	+$1.89M	0.73%	9
2019 Q1	–	Sell	-211	Closed	-$9K	–	671
2018 Q4	$9K	Buy	+211	New	+$8.76K	0.04%	602

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Pearl River Capital's PFE Position: Q3 2024 in Review

Pearl River Capital sold out of Pfizer (PFE) in Q3 2024, closing a stake of 235,388 shares — an estimated $6.59M sold.

Pearl River Capital first reported a position in PFE in Q4 2018 and held it in 13 quarters. The position peaked at $7M in Q3 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Pearl River Capital reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Pearl River Capital sold 235,388 Pfizer shares in Q3 2024, an estimated $6.59M.
Pearl River Capital first reported a position in Pfizer in Q4 2018 and held it in 13 quarters.
Pearl River Capital's Pfizer position peaked at $7M in Q3 2022.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.